The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER’S DISEASE: DESIGN AND BASELINE DATA
Open accessAbstract
Objective: The Multidomain Alzheimer Preventive Trial (MAPT study) was designed to assess the efficacy of isolated supplementation with omega-3 fatty acid, an isolated multidomain intervention (consisting of nutritional counseling, physical exercise, cognitive stimulation) or a combination of the two interventions on the change of cognitive functions in frail subjects aged 70 years and older for a period of 3 years. Ancillary neuroimaging studies were additionally implemented to evaluate the impact of interventions on cerebral metabolism (FDG PET scans) and atrophy rate (MRIs), as well as brain amyloïd deposit (AV45 PET scans). Design, patients: 1680 subjects (mean age: 75.3 years; female: 64.8 %), enrolled by 13 memory clinics, were randomized into one of the following four groups: omega-3 supplementation alone, multidomain intervention alone, omega-3 plus multidomain intervention, or placebo. Participants underwent cognitive, functional and biological assessments at M6, M12, M24 and M36 visits. The primary endpoint is a change of memory function at 3 years, as assessed by the Free and Cued Selective Reminding test. All participants will be followed for 2 additional years after the 3-years intervention (MAPT PLUS extension study). Interventions: 1/ Omega-3 supplementation: two soft capsules daily as a single dose, containing a total of 400 mg docosahexaenoic acid (DHA), i.e., 800 mg docosahexaenoic acid per day, for 3 years. 2/ Multidomain intervention: collective training sessions conducted in small groups (6–8 participants) in twelve 120-minute sessions over the first 2 months (two sessions a week for the first month, and one session a week the second month) then a 60-minute session per month in the following three areas: nutrition, physical activity, and cognition until the end of the 3 years. In addition to the collective sessions, individualized preventive outpatient visits exploring possible risk factors for cognitive decline are performed at baseline, M12 and M24. Baseline population: For cognition, the mean MMSE at baseline was 28.1 (± 1.6). About 58% and 42% of participants had a CDR score equal to 0 and 0.5, respectively. Regarding mobility status, 200 (11.9%) had a 4-m gait speed lower or equal to 0.8 m/s. According to the Fried criteria, 673 (42.1%) participants were considered pre frail, and 51 (3.2%) frail. The red blood cell DHA content was 26.1 ± 8.1 µg/g. Five hundred and three participants underwent baseline MRI. AV45 PET scans were performed in 271 individuals and preliminary results showed that 38.0% had a cortical SUVR > 1.17, which gave an indication of significant brain amyloïd deposit. Discussion: The MAPT trial is presently the first largest and longest multidomain preventive trial relevant to cognitive decline in older adults with subjective memory complaints. The multidomain intervention designed for the MAPT trial is likely to be easily implemented within the general population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,038
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J. M., & Wouters, E. J. M. (2016) · Gerontology · doi:10.1159/000430949 · Cited by 19,690
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. (2015) · Gerontology · doi:10.1159/000362720 · Cited by 18,909
Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living
Lawton, M. P., & Brody, E. M. (1969) · The Gerontologist · doi:10.1093/geront/9.3_part_1.179 · Cited by 18,540
Development and validation of a geriatric depression screening scale: a preliminary report
Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90033-4 · Cited by 15,025 · cited 1×
“- Depression as measured by the Geriatric Depression Scale – 15 items [GDS-15] (33).”
MethodMethods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Diagnostic and Statistical Manual of Mental Disorders
(2010) · Handbook of Disease Burdens and Quality of Life Measures · doi:10.1007/978-0-387-78665-0_5485 · Cited by 10,169
Validity of the Trail Making Test as an Indicator of Organic Brain Damage
Reitan, R. M. (1958) · Perceptual and Motor Skills · doi:10.2466/pms.1958.8.3.271 · Cited by 7,928
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Fried, L. P., Ferrucci, L., Darer, J., Williamson, J. D., & Anderson, G. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.3.m255 · Cited by 4,032
Cognitive Stimulation in Patients with Dementia: Randomized Controlled Trial
Mapelli, D., Di Rosa, E., Nocita, R., & Sava, D. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353457 · Cited by 3,453
Guralnik, J. M., Ferrucci, L., Pieper, C. F., Leveille, S. G., Markides, K. S., Ostir, G. V., Studenski, S., Berkman, L. F., & Wallace, R. B. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.4.m221 · Cited by 2,898
The projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,666
Katz, S. (1963) · JAMA · doi:10.1001/jama.1963.03060120024016 · Cited by 2,421
An active and socially integrated lifestyle in late life might protect against dementia
Fratiglioni, L., Paillard-Borg, S., & Winblad, B. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00767-7 · Cited by 2,135
Effects of Cognitive Training Interventions With Older Adults: A Randomized Controlled Trial
Ball, K., Berch, D. B., Helmers, K. F., Jobe, J. B., Leveck, M. D., Marsiske, M., Morris, J. N., Rebok, G. W., Smith, D. M., Tennstedt, S. L., et al. (2002) · JAMA · doi:10.1001/jama.288.18.2271 · Cited by 2,049
Self-citationRevising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869
Self-citationLong-term Effects of Cognitive Training on Everyday Functional Outcomes in Older Adults
Willis, S. L., Tennstedt, S. L., Marsiske, M., Ball, K., Elias, J., Koepke, K. M., Morris, J. N., Rebok, G. W., Unverzagt, F. W., Stoddard, A. M., et al. (2006) · JAMA · doi:10.1001/jama.296.23.2805 · Cited by 1,496
Self-citationKivipelto, M., Ngandu, T., Laatikainen, T., Winblad, B., Soininen, H., & Tuomilehto, J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70537-3 · Cited by 1,126
The I.A.N.A. task force on frailty assessment of older people in clinical practice
Van Kan, G. A., Rolland, Y., Bergman, H., Morley, J. E., Kritchevsky, S. B., & Vellas, B. (2008) · The Journal of nutrition, health and aging · doi:10.1007/bf02982161 · Cited by 1,099
Self-citationRebok, G. W., Ball, K., Guey, L. T., Jones, R. N., Kim, H., King, J. W., Marsiske, M., Morris, J. N., Tennstedt, S. L., Unverzagt, F. W., et al. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12607 · Cited by 965
Self-citationScreening for dementia by memory testing
Grober, E., Buschke, H., Crystal, H., Bang, S., & Dresner, R. (1988) · Neurology · doi:10.1212/wnl.38.6.900 · Cited by 961
Bherer, L., Erickson, K. I., & Liu-Ambrose, T. (2013) · Journal of Aging Research · doi:10.1155/2013/657508 · Cited by 899
Cardebat, D., Doyon, B., Puel, M., Goulet, P., & Joanette, Y. (1990) · PubMed · Cited by 698
Berendsen, A. A. M., Kang, J. H., van de Rest, O., Jankovic, N., Kampman, E., Kiefte-de Jong, J. C., Franco, O. H., Ikram, M. A., Pikhart, H., Nilsson, L. M., et al. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000464269 · Cited by 562
AD dementia risk in late MCI, in early MCI, and in subjective memory impairment.
Jessen, F., Wolfsgruber, S., Wiese, B., Bickel, H., Mösch, E., Kaduszkiewicz, H., Pentzek, M., Riedel‐Heller, S. G., Luck, T., Fuchs, A., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.09.017 · Cited by 511
Belleville, S., Gilbert, B., Fontaine, F., Gagnon, L., Ménard, É., & Gauthier, S. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000096316 · Cited by 421
Self-citationVellas, B., Coley, N., Ousset, P.-J., Berrut, G., Dartigues, J.-F., Dubois, B., Grandjean, H., Pasquier, F., Piette, F., Robert, P., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70206-5 · Cited by 398
Self-citationJoshi, A. D., Pontecorvo, M. J., Clark, C. M., Carpenter, A. P., Jennings, D. L., Sadowsky, C. H., Adler, L. P., Kovnat, K. D., Seibyl, J. P., Arora, A., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.090340 · Cited by 391
The French National Nutrition and Health Program: 2001–2006–2010
Hercberg, S., Chat-Yung, S., & Chauliac, M. (2008) · International Journal of Public Health · doi:10.1007/s00038-008-7016-2 · Cited by 328
Wengreen, H., Munger, R. G., Cutler, A., Quach, A., Bowles, A., Corcoran, C., Tschanz, J. T., Norton, M. C., & Welsh-Bohmer, K. A. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.051276 · Cited by 264
Fitzpatrick, A. L., Buchanan, C. K., Nahin, R. L., DeKosky, S. T., Atkinson, H. H., Carlson, M. C., Williamson, J. D., & for the Ginkgo Evaluation of Memory (GEM) Study Investigators (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.11.1244 · Cited by 250
Sanders, T. A. B., Ellis, F. R., & Dickerson, J. W. T. (1978) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/31.5.805 · Cited by 246
Nourhashemi, F., Andrieu, S., Gillette-Guyonnet, S., Vellas, B., Albarede, J. L., & Grandjean, H. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.7.m448 · Cited by 240
Self-citationGalasko, D., Bennett, D. A., Sano, M., Marson, D., Kaye, J., & Edland, S. D. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213873.25053.2b · Cited by 192
Nutrition and neurodegeneration: epidemiological evidence and challenges for future research
Gillette‐Guyonnet, S., Secher, M., & Vellas, B. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12058 · Cited by 187
Self-citationDementia Prevention: Methodological Explanations for Inconsistent Results
Coley, N., Andrieu, S., Gardette, V., Guyonnet, S., Sanz, C., Vellas, B. J., & Grand, A. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn010 · Cited by 171
Self-citationGray matter atrophy pattern in elderly with subjective memory impairment
Peter, J., Scheef, L., Abdulkadir, A., Boecker, H., Heneka, M., Wagner, M., Koppara, A., Klöppel, S., Jessen, F., & Initiative, A. D. N. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.05.1764 · Cited by 165 · cited 1×
“Recently, studies have also observed hippocampal atrophy in subjects with memory complaints compared to those with no memory complaint (11).”
BackgroundEndpoints for trials in Alzheimer's disease: a European task force consensus
Vellas, B. J., Andrieu, S., Sampaio, C., Coley, N., & Wilcock, G. K. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70087-5 · Cited by 165
Self-citationGifford, K. A., Liu, D., Lu, Z., Tripodis, Y., Cantwell, N. G., Palmisano, J., Kowall, N., & Jefferson, A. L. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.02.007 · Cited by 159
Weill, P., Schmitt, B., Chesneau, G., Daniel, N., Safraou, F., & Legrand, P. (2002) · Annals of Nutrition and Metabolism · doi:10.1159/000065405 · Cited by 159
Self-citationder Linden, M. V., Adam, S., Agniel, A., Mouly, C., & du Gremem, M. (2004) · Cited by 135
Can we prevent Alzheimer's disease? Secondary “prevention” trials in Alzheimer's disease
Carrillo, M. C., Brashear, H. R., Logovinsky, V., Ryan, J. M., Feldman, H., Siemers, E., Abushakra, S. R., Hartley, D. M., Petersen, R. C., Khachaturian, A. S., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.12.004 · Cited by 129
Guyonnet, S., Andrieu, S., DANTOINE, T. F., Dartigues, J., Touchon, J., Vellas, B. J., & MAPT Study Group (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.01.008 · Cited by 123
Self-citationRichard, E., Andrieu, S., Solomon, A., Mangialasche, F., Ahtiluoto, S., van Charante, E. P. M., Coley, N., Fratiglioni, L., Neely, A. S., Vellas, B., et al. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.06.012 · Cited by 121
Self-citationDoes 8-foot walk time predict cognitive decline in older Mexicans Americans?
Alfaro‐Acha, A., Al Snih, S., Raji, M. A., Markides, K. S., & Ottenbacher, K. J. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01039.x · Cited by 106
A review of multidomain interventions to support healthy cognitive ageing
Schneider, N., & Yvon, C. (2012) · The journal of nutrition health & aging · doi:10.1007/s12603-012-0402-8 · Cited by 105
Ruthirakuhan, M. T., Luedke, A. C., Tam, A., Goel, A., Kurji, A., & Garcia, A. A. (2012) · Journal of Aging Research · doi:10.1155/2012/384875 · Cited by 100
Dacks, P. A., Shineman, D. W., & Fillit, H. M. (2013) · The journal of nutrition health & aging · doi:10.1007/s12603-012-0431-3 · Cited by 78
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008
Khachaturian, Z. S. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.01.021 · Cited by 77
Carrié, I., van Kan, G. A., Guyonnet, S., Andrieu, S., Dartigues, J.-F., Touchon, J., DANTOINE, T. F., Rouaud, O., Bonnefoy, M., Robert, P. H., et al. (2012) · The journal of nutrition health & aging · doi:10.1007/s12603-012-0046-8 · Cited by 68
Self-citationLegrand, P., Schmitt, B. A., Mourot, J., Catheline, D., Chesneau, G., Mireaux, M., Kerhoas, N., & Weill, P. (2009) · Lipids · doi:10.1007/s11745-009-3376-5 · Cited by 57
Self-citationMethodological Issues in Primary Prevention Trials for Neurodegenerative Dementia
Andrieu, S., Coley, N., Aisen, P. S. S., Carrillo, M. C., DeKosky, S. T., Durga, J., Fillit, H. M., Frisoni, G. B., Froelich, L., Gauthier, S. G., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0971 · Cited by 49
Self-citationMemory complaints to the general practitioner: Data from the GuidAge study
Coley, N., Ousset, P., Andrieu, S., Mathiex‐Fortunet, H., & Vellas, B. J. (2008) · The journal of nutrition health & aging · doi:10.1007/bf02982590 · Cited by 38
Self-citationPUFA for Prevention and Treatment of Dementia?
Carrié, I., Abellan, G., Rolland, Y., Guyonnet, S., & Vellas, B. J. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789909764 · Cited by 38
Self-citationIAGG Workshop: Health promotion program on prevention of late onset dementia
Andrieu, S., Aboderin, I., Baeyens, J., Beard, J., Benetos, A., Berrut, G., Brainin, M., Cha, H. B., Chen, L. K., Du, P., et al. (2011) · The journal of nutrition health & aging · doi:10.1007/s12603-011-0142-1 · Cited by 33
Self-citationGuyonnet, S., van Kan, G. A., Andrieu, S., Aquino, J. P. R., Arbus, C., Becq, J.-P., Berr, C., Bismuth, S., Chamontin, B., DANTOINE, T. F., et al. (2008) · The journal of nutrition health & aging · doi:10.1007/bf02983204 · Cited by 27
Self-citationThe European Dementia Prevention Initiative
Dehnel, T. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70030-9 · Cited by 20
Sirot, V., Dumas, C., Desquilbet, L., Mariotti, F., Legrand, P., Catheline, D., Leblanc, J., & Margaritis, I. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.06.007 · Cited by 14
Self-citation
Cited by
Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease
Kivipelto, M., Mangialasche, F., & Ngandu, T. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0070-3 · Cited by 1,173
Andrieu, S., Guyonnet, S., Coley, N., Cantet, C., Bonnefoy, M., Bordes, S., Bories, L., Cufi, M.-N., Dantoine, T., Dartigues, J.-F., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30040-6 · Cited by 838
Self-citationAlzheimer’s disease prevention: from risk factors to early intervention
Crous-Bou, M., Minguillón, C., Gramunt, N., & Molinuevo, J. L. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0297-z · Cited by 687
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub3 · Cited by 630
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub4 · Cited by 405
Metadata
- Authors
- Vellas, B., Gillette-Guyonnet, S., Touchon, J., Dantoine, T., Dartigues, J. F., Cuffi, M. N., Bordes, S., Gasnier, Y., Robert, P., Bories, L., Rouaud, O., Desclaux, F., Sudres, K., Bonnefoy, M., Pesce, A., Dufouil, C., Lehericy, S., Chupin, M., Mangin, J. F., Payoux, P., Adel, D., Legrand, P., Catheline, D., Kanony, C., Zaim, M., Molinier, L., Costa, N., Delrieu, J., Voisin, T., Faisant, C., Lala, F., Nourhashemi, F., Rolland, Y., Abellan Van Kan, G., Dupuy, C., Cantet, C., Cestac, P., Belleville, S., Willis, S., Cesari, M., Weiner, M. W., Soto, M. E., Ousset, P. J., Andrieu, S., & Carrie, I.
- Venue
- The Journal Of Prevention of Alzheimer's Disease
- Publisher
- Elsevier BV
- Published
- 2014
- Volume
- 1
- Issue
- 1
- Pages
- 1-10
- ISSN
- 2274-5807 (ISSN-L)
- OpenAlex
- W2183174223
- Cited by
- 255
- References
- 63
- FWCI
- 13.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.